 LA JOLLA, Calif., Aug. 03, 2021 GLOBE NEWSWIRE -- Singular Genomics Systems, Inc., a company focused on delivering genomic technologies for the advancement of science and medicine, today reported its second quarter 2021 financial results and highlighted recent operating and corporate achievements. Investors and the general public are invited to view the companys quarterly report, filed today on Form 10-Q with the Securities and Exchange Commission 